chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: soreness; achy pain in joints from waist/hip down on right side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) and ARTHRALGIA (achy pain in joints from waist/hip down on right side) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Ache NOS.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced ARTHRALGIA (achy pain in joints from waist/hip down on right side). On an unknown date, the patient experienced PAIN (soreness). At the time of the report, PAIN (soreness) and ARTHRALGIA (achy pain in joints from waist/hip down on right side) had resolved.            No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Updated the relevant medical history and newevent was added and updated the outcome of the event from unknown to resolved.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Hives on  back legs, arms and stomach; itchiness on  back legs, arms and stomach; Rash on back legs, arms and stomach; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on  back legs, arms and stomach), PRURITUS (itchiness on  back legs, arms and stomach) and RASH (Rash on back legs, arms and stomach) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concomitant products included CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE E) and HYDROXYZINE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced URTICARIA (Hives on  back legs, arms and stomach), PRURITUS (itchiness on  back legs, arms and stomach) and RASH (Rash on back legs, arms and stomach). At the time of the report, URTICARIA (Hives on  back legs, arms and stomach), PRURITUS (itchiness on  back legs, arms and stomach) and RASH (Rash on back legs, arms and stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  Treatment medication included Anti Itch Cream and Anti Itch Pill.  She thought it might be shingles, but confirmed not to be shingles by her dermatologist. The dermatologist gave her Clobetasol propionate cream 0.05%. She went to an allergist Friday that prescribed her hydroxzine 25 mg tab, which she is only taking a half a pill because they make her drowsy.   Most recent FOLLOW-UP information incorporated above includes: On 19-Mar-2021: No specific follow-up information recorded.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Gait disturbance, Pain, Rash, Salivary hypersecretion
Clinical narrative: stinging pain; large protrusion size of half egg, not solid; salivating; poor gait; weak; swelling, large protrusion size of half egg; rash; tender and sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait) and ASTHENIA (weak) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    The patient's past medical history included No adverse event (No medical history was provided.).   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait), ASTHENIA (weak), SWELLING (swelling, large protrusion size of half egg), RASH (rash) and VACCINATION SITE PAIN (tender and sore). At the time of the report, PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait), ASTHENIA (weak), SWELLING (swelling, large protrusion size of half egg), RASH (rash) and VACCINATION SITE PAIN (tender and sore) outcome was unknown.            This case was linked to MOD-2021-051626 (Patient Link).   Reporter did not allow further contact
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Vaccination site mass, Vaccination site pain
Clinical narrative: stinging pain; large protrusion size of half egg, not solid; salivating; poor gait; weak; swelling, large protrusion size of half egg; rash; tender and sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait) and ASTHENIA (weak) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    The patient's past medical history included No adverse event (No medical history was provided.).   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait), ASTHENIA (weak), SWELLING (swelling, large protrusion size of half egg), RASH (rash) and VACCINATION SITE PAIN (tender and sore). At the time of the report, PAIN (stinging pain), VACCINATION SITE MASS (large protrusion size of half egg, not solid), SALIVARY HYPERSECRETION (salivating), GAIT DISTURBANCE (poor gait), ASTHENIA (weak), SWELLING (swelling, large protrusion size of half egg), RASH (rash) and VACCINATION SITE PAIN (tender and sore) outcome was unknown.            This case was linked to MOD-2021-051626 (Patient Link).   Reporter did not allow further contact
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Nausea
Clinical narrative: "nausea during 20 minutes''; small fatigue; pain in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in shoulder), NAUSEA ("nausea during 20 minutes'') and FATIGUE (small fatigue) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History were Reported.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced ARTHRALGIA (pain in shoulder). On 18-Mar-2021, the patient experienced NAUSEA ("nausea during 20 minutes'') and FATIGUE (small fatigue). On 18-Mar-2021, ARTHRALGIA (pain in shoulder), NAUSEA ("nausea during 20 minutes'') and FATIGUE (small fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medicines were not provided by reporter
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (sore at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (sore at the injection site). At the time of the report, INJECTION SITE PAIN (sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-051690 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051690:Patient's case
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site reaction
Clinical narrative: "big spot" at the injection site; "itches real bad"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("big spot" at the injection site) and VACCINATION SITE PRURITUS ("itches real bad") in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE REACTION ("big spot" at the injection site) and VACCINATION SITE PRURITUS ("itches real bad"). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION ("big spot" at the injection site) and VACCINATION SITE PRURITUS ("itches real bad") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment drug: Benadryl No concomitant medications provided. No medical history reported
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: itching; redness; sore at injection site; hard knot/raised/bumpy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (sore at injection site), VACCINATION SITE INDURATION (hard knot/raised/bumpy at injection site) and VACCINATION SITE PRURITUS (itching) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included OLMESARTAN and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (sore at injection site) and VACCINATION SITE INDURATION (hard knot/raised/bumpy at injection site). On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching). On 16-Mar-2021, VACCINATION SITE ERYTHEMA (redness) had resolved. At the time of the report, VACCINATION SITE PAIN (sore at injection site), VACCINATION SITE INDURATION (hard knot/raised/bumpy at injection site) and VACCINATION SITE PRURITUS (itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No laboratory details were  provided.  No treatment medications were reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore Arm; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown. Not Provided          No concomitant medication was provided. No treatment drugs was included.   This case was linked to US-MODERNATX, INC.-MOD-2021-051613, MOD-2021-052287 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051613:1st dose MOD-2021-052287:Patient information
Sex: M
Vaccine: COVID19
Symptoms: Dysarthria, Ear pain, Ocular discomfort, Oropharyngeal pain, Poor quality sleep
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (Sore on the left side of the throat), EAR PAIN (Throbbing earache on the left side), OCULAR DISCOMFORT (Problems with my left eye), POOR QUALITY SLEEP (These symptoms are affecting my sleep and speech) and DYSARTHRIA (These symptoms are affecting my sleep and speech) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ZINC for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore on the left side of the throat), EAR PAIN (Throbbing earache on the left side), OCULAR DISCOMFORT (Problems with my left eye), POOR QUALITY SLEEP (These symptoms are affecting my sleep and speech) and DYSARTHRIA (These symptoms are affecting my sleep and speech). At the time of the report, OROPHARYNGEAL PAIN (Sore on the left side of the throat), EAR PAIN (Throbbing earache on the left side) and OCULAR DISCOMFORT (Problems with my left eye) had not resolved and POOR QUALITY SLEEP (These symptoms are affecting my sleep and speech) and DYSARTHRIA (These symptoms are affecting my sleep and speech) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicines include Zinc, Vitamin D, Vitamin c  Treatment medicines include Antibiotic, Pain killer medications  Action taken with mRNA-1273 in response to the event was unknown
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Hyperhidrosis, Nausea
Clinical narrative: dizziness; sweating; fever (T102-103F) for five hours/running a low grade temperature; extreme nausea; extreme chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HYPERHIDROSIS (sweating), NAUSEA (extreme nausea), CHILLS (extreme chills) and HEADACHE (headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced NAUSEA (extreme nausea), CHILLS (extreme chills) and HEADACHE (headache). On 11-Mar-2021, the patient experienced PYREXIA (fever (T102-103F) for five hours/running a low grade temperature). On 12-Mar-2021, the patient experienced DIZZINESS (dizziness) and HYPERHIDROSIS (sweating). On 10-Mar-2021, CHILLS (extreme chills) had resolved. On 12-Mar-2021, NAUSEA (extreme nausea) had resolved. At the time of the report, DIZZINESS (dizziness), HYPERHIDROSIS (sweating), HEADACHE (headache) and PYREXIA (fever (T102-103F) for five hours/running a low grade temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: dizziness; sweating; fever (T102-103F) for five hours/running a low grade temperature; extreme nausea; extreme chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HYPERHIDROSIS (sweating), NAUSEA (extreme nausea), CHILLS (extreme chills) and HEADACHE (headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced NAUSEA (extreme nausea), CHILLS (extreme chills) and HEADACHE (headache). On 11-Mar-2021, the patient experienced PYREXIA (fever (T102-103F) for five hours/running a low grade temperature). On 12-Mar-2021, the patient experienced DIZZINESS (dizziness) and HYPERHIDROSIS (sweating). On 10-Mar-2021, CHILLS (extreme chills) had resolved. On 12-Mar-2021, NAUSEA (extreme nausea) had resolved. At the time of the report, DIZZINESS (dizziness), HYPERHIDROSIS (sweating), HEADACHE (headache) and PYREXIA (fever (T102-103F) for five hours/running a low grade temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: dizziness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Chronic pain.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (dizziness) and NAUSEA (nausea). At the time of the report, DIZZINESS (dizziness) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Gait disturbance, Gait inability, Headache
Clinical narrative: balance has not been good; headaches on both side of head; cold; difficulty walking; difficulty bending knees; Felt like partial disability; muscle pains around waist; chills; Developed a rash; intense pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (intense pain), NASOPHARYNGITIS (cold), GAIT DISTURBANCE (difficulty walking), JOINT STIFFNESS (difficulty bending knees) and GAIT INABILITY (Felt like partial disability) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (intense pain) and RASH (Developed a rash). On 18-Mar-2021, the patient experienced CHILLS (chills). On 19-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), GAIT DISTURBANCE (difficulty walking), JOINT STIFFNESS (difficulty bending knees), GAIT INABILITY (Felt like partial disability) and MYALGIA (muscle pains around waist). On 20-Mar-2021, the patient experienced BALANCE DISORDER (balance has not been good) and HEADACHE (headaches on both side of head). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, PAIN (intense pain), NASOPHARYNGITIS (cold), GAIT DISTURBANCE (difficulty walking), JOINT STIFFNESS (difficulty bending knees), GAIT INABILITY (Felt like partial disability), BALANCE DISORDER (balance has not been good), RASH (Developed a rash), HEADACHE (headaches on both side of head), CHILLS (chills) and MYALGIA (muscle pains around waist) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Joint stiffness, Myalgia, Nasopharyngitis, Pain, Rash
Clinical narrative: balance has not been good; headaches on both side of head; cold; difficulty walking; difficulty bending knees; Felt like partial disability; muscle pains around waist; chills; Developed a rash; intense pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (intense pain), NASOPHARYNGITIS (cold), GAIT DISTURBANCE (difficulty walking), JOINT STIFFNESS (difficulty bending knees) and GAIT INABILITY (Felt like partial disability) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (intense pain) and RASH (Developed a rash). On 18-Mar-2021, the patient experienced CHILLS (chills). On 19-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), GAIT DISTURBANCE (difficulty walking), JOINT STIFFNESS (difficulty bending knees), GAIT INABILITY (Felt like partial disability) and MYALGIA (muscle pains around waist). On 20-Mar-2021, the patient experienced BALANCE DISORDER (balance has not been good) and HEADACHE (headaches on both side of head). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, PAIN (intense pain), NASOPHARYNGITIS (cold), GAIT DISTURBANCE (difficulty walking), JOINT STIFFNESS (difficulty bending knees), GAIT INABILITY (Felt like partial disability), BALANCE DISORDER (balance has not been good), RASH (Developed a rash), HEADACHE (headaches on both side of head), CHILLS (chills) and MYALGIA (muscle pains around waist) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy rash on her stomach, back and shoulder; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash on her stomach, back and shoulder) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash on her stomach, back and shoulder). At the time of the report, RASH PRURITIC (Itchy rash on her stomach, back and shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  Treatment details included Desonide cream, Allegra.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Pain, Pyrexia
Clinical narrative: Dry cough; body ache; chills; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (slight fever), PAIN (body ache) and COUGH (Dry cough) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (slight fever), PAIN (body ache) and COUGH (Dry cough). At the time of the report, CHILLS (chills), PYREXIA (slight fever), PAIN (body ache) and COUGH (Dry cough) outcome was unknown. Not Provided          No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HEADACHE (headache). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at a dose of 1 UNK and VITAMINS NOS (DAILY VITAMINS) for Adverse event, at a dose of 1 UNK. On 20-Feb-2021, HEADACHE (headache) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant meidcations were reported.   This case was linked to MOD-2021-051632 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Follow up received on 09-MAY-2021 contains no new information
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Pain in extremity
Clinical narrative: Sore arm; she received expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and EXPIRED PRODUCT ADMINISTERED (she received expired vaccine) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001821A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and EXPIRED PRODUCT ADMINISTERED (she received expired vaccine). On 19-Mar-2021, EXPIRED PRODUCT ADMINISTERED (she received expired vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hyperhidrosis, Myalgia, Pyrexia, Tremor
Clinical narrative: shaky; I threw up whatever I tried to eat; I was so sick last night; I could not get dressed; i would rather die; sweating; aches all over; fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), VACCINATION COMPLICATION (I was so sick last night), ASTHENIA (I could not get dressed), VACCINATION COMPLICATION (i would rather die) and TREMOR (shaky) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), MYALGIA (aches all over) and PYREXIA (fever). On 18-Mar-2021, the patient experienced VACCINATION COMPLICATION (I was so sick last night), ASTHENIA (I could not get dressed), VACCINATION COMPLICATION (i would rather die) and VOMITING (I threw up whatever I tried to eat). On 19-Mar-2021, the patient experienced TREMOR (shaky). On 19-Mar-2021, HYPERHIDROSIS (sweating), VACCINATION COMPLICATION (I was so sick last night), ASTHENIA (I could not get dressed), VACCINATION COMPLICATION (i would rather die), VOMITING (I threw up whatever I tried to eat), MYALGIA (aches all over) and PYREXIA (fever) had resolved. At the time of the report, TREMOR (shaky) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  Treatment medication included Tylenol  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vomiting
Clinical narrative: shaky; I threw up whatever I tried to eat; I was so sick last night; I could not get dressed; i would rather die; sweating; aches all over; fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), VACCINATION COMPLICATION (I was so sick last night), ASTHENIA (I could not get dressed), VACCINATION COMPLICATION (i would rather die) and TREMOR (shaky) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), MYALGIA (aches all over) and PYREXIA (fever). On 18-Mar-2021, the patient experienced VACCINATION COMPLICATION (I was so sick last night), ASTHENIA (I could not get dressed), VACCINATION COMPLICATION (i would rather die) and VOMITING (I threw up whatever I tried to eat). On 19-Mar-2021, the patient experienced TREMOR (shaky). On 19-Mar-2021, HYPERHIDROSIS (sweating), VACCINATION COMPLICATION (I was so sick last night), ASTHENIA (I could not get dressed), VACCINATION COMPLICATION (i would rather die), VOMITING (I threw up whatever I tried to eat), MYALGIA (aches all over) and PYREXIA (fever) had resolved. At the time of the report, TREMOR (shaky) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  Treatment medication included Tylenol  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Tinnitus, Vaccination site pain
Clinical narrative: arm pain near injection site; ringing in ears lasted 1 minute; pressure in ears lasted 1 minute; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in ears lasted 1 minute), EAR DISCOMFORT (pressure in ears lasted 1 minute) and VACCINATION SITE PAIN (arm pain near injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced TINNITUS (ringing in ears lasted 1 minute) and EAR DISCOMFORT (pressure in ears lasted 1 minute). On an unknown date, the patient experienced VACCINATION SITE PAIN (arm pain near injection site). At the time of the report, TINNITUS (ringing in ears lasted 1 minute) and EAR DISCOMFORT (pressure in ears lasted 1 minute) had resolved and VACCINATION SITE PAIN (arm pain near injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Vaccination site induration, Vaccination site mass, Vaccination site pain, Vaccination site pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard knot at injection site), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE PAIN (Injection site hurts) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low). On 20-Mar-2021, the patient experienced VACCINATION SITE MASS (Hard knot at injection site), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (Injection site hurts) and VACCINATION SITE SWELLING (injection site swollen). On 13-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low) had resolved. At the time of the report, VACCINATION SITE MASS (Hard knot at injection site), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (Injection site hurts) and VACCINATION SITE SWELLING (injection site swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No reported concomitant medications.  No treatment information provided.  This report refers to a case of Inappropriate route of vaccination for mRNA-1273, lot # 038A21A.Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: This report refers to a case of Inappropriate route of vaccination for mRNA-1273, lot # 038A21A.Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard knot at injection site), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy) and VACCINATION SITE PAIN (Injection site hurts) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low). On 20-Mar-2021, the patient experienced VACCINATION SITE MASS (Hard knot at injection site), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (Injection site hurts) and VACCINATION SITE SWELLING (injection site swollen). On 13-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccinator gave injection too low) had resolved. At the time of the report, VACCINATION SITE MASS (Hard knot at injection site), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE PAIN (Injection site hurts) and VACCINATION SITE SWELLING (injection site swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No reported concomitant medications.  No treatment information provided.  This report refers to a case of Inappropriate route of vaccination for mRNA-1273, lot # 038A21A.Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: This report refers to a case of Inappropriate route of vaccination for mRNA-1273, lot # 038A21A.Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Eye pain, Sensitive skin
Clinical narrative: back pain (from the neck down to the buttocks area on the right side and from the lower back down to the buttocks area on the left side); painful when he squeezed his eyes tightly; hypersensitive skin; wrist pains; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain (from the neck down to the buttocks area on the right side and from the lower back down to the buttocks area on the left side)), EYE PAIN (painful when he squeezed his eyes tightly), SENSITIVE SKIN (hypersensitive skin) and ARTHRALGIA (wrist pains) in a 68-year-old male patient who received mRNA-1273 (batch nos. 040A21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced BACK PAIN (back pain (from the neck down to the buttocks area on the right side and from the lower back down to the buttocks area on the left side)), EYE PAIN (painful when he squeezed his eyes tightly), SENSITIVE SKIN (hypersensitive skin) and ARTHRALGIA (wrist pains). On 12-Mar-2021, BACK PAIN (back pain (from the neck down to the buttocks area on the right side and from the lower back down to the buttocks area on the left side)), EYE PAIN (painful when he squeezed his eyes tightly), SENSITIVE SKIN (hypersensitive skin) and ARTHRALGIA (wrist pains) had resolved.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration
Clinical narrative: Purple dots on left upper arm near injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Purple dots on left upper arm near injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Purple dots on left upper arm near injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (Purple dots on left upper arm near injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little soreness in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little soreness in the arm). At the time of the report, PAIN IN EXTREMITY (little soreness in the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Limb discomfort, Peripheral swelling
Clinical narrative: can't even sleep at night; still swollen; couldn't lift her arm/ All week she still couldn't and she still can't lift it fully; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (couldn't lift her arm/ All week she still couldn't and she still can't lift it fully), INSOMNIA (can't even sleep at night) and PERIPHERAL SWELLING (still swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Mar-2021, the patient experienced LIMB DISCOMFORT (couldn't lift her arm/ All week she still couldn't and she still can't lift it fully). On an unknown date, the patient experienced INSOMNIA (can't even sleep at night) and PERIPHERAL SWELLING (still swollen). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (couldn't lift her arm/ All week she still couldn't and she still can't lift it fully) and INSOMNIA (can't even sleep at night) outcome was unknown and PERIPHERAL SWELLING (still swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicines are not provided by the reporter  Patient stated the shot was given very high up on the shoulder and thinks it could have interfered with the arm bone.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Reporter declines to complete ADR  form
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pyrexia, Vaccination site pain
Clinical narrative: SWEATING; fever; soreness in the arm  after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), VACCINATION SITE PAIN (soreness in the arm  after the first dose) and HYPERHIDROSIS (SWEATING) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PYREXIA (fever) and VACCINATION SITE PAIN (soreness in the arm  after the first dose). On 17-Mar-2021, the patient experienced HYPERHIDROSIS (SWEATING). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Mar-2021, PYREXIA (fever), VACCINATION SITE PAIN (soreness in the arm  after the first dose) and HYPERHIDROSIS (SWEATING) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: red blotchy spot in her chest her face, neck and chest and also at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red blotchy spot in her chest her face, neck and chest and also at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red blotchy spot in her chest her face, neck and chest and also at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (red blotchy spot in her chest her face, neck and chest and also at the injection site) outcome was unknown. Not Provided          No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD21-058370 (E2B Linked Report).; Sender's Comments:  MOD21-058370:Cross-Linked Case
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: very dizzy; headache at the back of the head; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (very dizzy) and HEADACHE (headache at the back of the head) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 10-Mar-2021, the patient experienced DIZZINESS (very dizzy) and HEADACHE (headache at the back of the head). At the time of the report, DIZZINESS (very dizzy) and HEADACHE (headache at the back of the head) outcome was unknown.            Treatment details included aspirin, acetaminophen and caffeine.